Featured Research

from universities, journals, and other organizations

Study Says Rare Allergic Reactions To Drug-eluting Stents May Raise Risk For Heart Attack

Date:
March 17, 2005
Source:
Emory University Health Sciences Center
Summary:
Stents, tiny wire mesh tubes, are routinely used to prop arteries open after angioplasty clears them of potentially heart attack causing plaque. In the past, stented arteries often eventually closed up again with fatty deposits, a process called restenosis. However, since their FDA approval in 2003, stents coated with sirolimus (a pharmaceutical agent that prevents excess tissue growth) have been shown to greatly reduce restenosis. But some people suffer from rare, allergic-type reactions to the sirolimus-eluting stents (SES).

ORLANDO -- Stents, tiny wire mesh tubes, are routinely used to prop arteries open after angioplasty clears them of potentially heart attack causing plaque. In the past, stented arteries often eventually closed up again with fatty deposits, a process called restenosis. However, since their FDA approval in 2003, stents coated with sirolimus (a pharmaceutical agent that prevents excess tissue growth) have been shown to greatly reduce restenosis. But some people suffer from rare, allergic-type reactions to the sirolimus-eluting stents (SES).

Related Articles


According to research presented by Emory scientists at the American College of Cardiology's 54th annual Scientific Sessions in Orlando today, these hypersensitivity reactions to SES should be caught and treated early -- because those allergic to components of the drug-eluting stents appear to have a higher risk of cardiovascular complications, including heart attacks.

"Reports of stent thrombosis first raised suspicion of possible hypersensitivity allergic reactions. After more than 50 reports of hypersensitivity reactions to SES were received by the FDA through the medical device reporting system, the FDA issued a warning in the fall of 2003," says Emory Heart Center Interventional Cardiology Fellow Fadi Alameddine, MD. "We studied the frequency of hypersensitive reactions to SES to see whether they were linked to major adverse cardiovascular outcomes."

Dr. Alameddine, lead author of the research presented at a poster session today, notes that hypersensitivity to SES could be caused by the stent's metal, polymer, or sirolimus. In order to evaluate whether allergic reactions might result from components of the Cypher drug eluting stent made by Cordis, a team of Emory researchers examined data collected from a U.S. registry of patients implanted with the Cypher SES. Out of 2067 patients who received the Cypher stents between August and December of 2003, 39 patients (1.9%) had what appeared to be allergic reactions. Although non-Cypher stent causes were found in 28 patients with hypersensitivity reactions the remaining 11 patients had hypersensitivity symptoms (ranging from rash and hives to asthma) believed to be caused by SES.

"The group with the hypersensitivity reactions had a higher major adverse cardiovascular events (MACE) rate and there was a trend toward the need for target vessel revascularization (TVR). Most significantly, the 180 day myocardial infarction (MI) rate was statistically higher in the hypersensitivity group (7.9% vs. 1.1%)," says Dr. Alameddine.

The Emory researchers postulate that a hypersensitivity reaction may reflect a heightened inflammatory state, creating a predisposition for heart attack. "Another possible, but less likely, explanation for the increase in MI is that hypersensitivity might cause plaque in other coronary beds to become more vulnerable to rupture," says Dr. Alameddine.

Although the research needs to be confirmed by randomized controlled prospective trials, the observations indicate that careful monitoring for allergic reactions should follow deployment of drug-eluting stents, according to Dr. Alameddine. "The bottom line is that these reactions are very rare (about 1.8 percent). However, they can happen hours to weeks after stent deployment and physicians need to be aware of that possibility -- and when hypersensitivity does occur it needs to be treated in a timely manner and the increased risk of MI should be recognized," Dr. Alameddine states.

In addition to Dr. Alameddine, the research team included Aniket Kulkarn MD; Viola Vaccarino MD, PhD; and Peter C. Block, MD of Emory University Division of Cardiology, and Peter B. Berger, MD of Duke University Medical Center's Division of Cardiology. Dr. Berger disclosed commercial relationships with Bristol Myer Squibb/Sanofi, Cordis-Johnson & Johnson, Merck, Aventis, The Medicines Company, Genentech, and Guilford; Dr. Block, with Cordis-Johnson & Johnson.

###

The Emory Heart Center is comprised of all cardiac services and research at Emory University Hospital, the Carlyle Fraser Heart Center of Emory Crawford Long Hospital, the Andreas Gruentzig Cardiovascular Center of Emory University and The Emory Clinic. Ranked among the nation's top ten heart centers by U.S. News & World Report's annual survey, the Emory Heart Center has a rich history of excellence in all areas of cardiology and cardiac surgery --including education, research and patient care. It is internationally recognized as one of the birthplaces of modern interventional cardiology and was the site of the first coronary stent implantation in the United States, the only single site randomized comparison of angioplasty and bypass surgery, and pioneering work in vascular brachytherapy.


Story Source:

The above story is based on materials provided by Emory University Health Sciences Center. Note: Materials may be edited for content and length.


Cite This Page:

Emory University Health Sciences Center. "Study Says Rare Allergic Reactions To Drug-eluting Stents May Raise Risk For Heart Attack." ScienceDaily. ScienceDaily, 17 March 2005. <www.sciencedaily.com/releases/2005/03/050310110311.htm>.
Emory University Health Sciences Center. (2005, March 17). Study Says Rare Allergic Reactions To Drug-eluting Stents May Raise Risk For Heart Attack. ScienceDaily. Retrieved December 18, 2014 from www.sciencedaily.com/releases/2005/03/050310110311.htm
Emory University Health Sciences Center. "Study Says Rare Allergic Reactions To Drug-eluting Stents May Raise Risk For Heart Attack." ScienceDaily. www.sciencedaily.com/releases/2005/03/050310110311.htm (accessed December 18, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, December 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Kids Die While Under Protective Services

Kids Die While Under Protective Services

AP (Dec. 18, 2014) As part of a six-month investigation of child maltreatment deaths, the AP found that hundreds of deaths from horrific abuse and neglect could have been prevented. AP's Haven Daley reports. (Dec. 18) Video provided by AP
Powered by NewsLook.com
UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com
When You Lose Weight, This Is Where The Fat Goes

When You Lose Weight, This Is Where The Fat Goes

Newsy (Dec. 17, 2014) Can fat disappear into thin air? New research finds that during weight loss, over 80 percent of a person's fat molecules escape through the lungs. Video provided by Newsy
Powered by NewsLook.com
Why Your Boss Should Let You Sleep In

Why Your Boss Should Let You Sleep In

Newsy (Dec. 17, 2014) According to research out of the University of Pennsylvania, waking up for work is the biggest factor that causes Americans to lose sleep. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins